Ballance David James 4
4 · PhaseBio Pharmaceuticals Inc · Filed Feb 14, 2020
Insider Transaction Report
Form 4
Ballance David James
VP, Research and Sci. Affairs
Transactions
- Award
Employee Stock Option (right to buy)
2020-02-12+55,000→ 55,000 totalExercise: $5.19Exp: 2030-02-12→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in equal monthly installments over 48 months from February 12, 2020, subject to the reporting person's continued service through each such date.